The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 694 KB, PDF document
Purpose: Principal component analysis (PCA) is a mathematical model which simplifies data into new, combined variables. Optimal treatment of pediatric congenital adrenal hyperplasia (CAH) remains a challenge and requires evaluation of all biochemical and clinical markers. The aim of this study was to introduce PCA methodology as a tool to optimize management in a cohort of pediatric and adolescent patients with CAH by including adrenal steroid measurements and clinical parameters. Methods: This retrospective, longitudinal cohort of 33 children and adolescents with CAH due to 21-hydroxylase deficiency included 406 follow-up observations. PCAs were applied to serum hormone concentrations and compared to treatment efficacy evaluated by clinical parameters. Results: We provide and describe the first PCA models with hormone parameters denoted in sex- and age-adjusted standard deviation (SD) scores to comprehensibly describe the combined ‘endocrine profiles’ of patients with classical and non-classical CAH, respectively. Endocrine profile scores were predictive markers of treatment efficacy for classical (AUC=92%; accuracy 95%; p=1.8e-06) and non-classical CAH (AUC=80%; accuracy 91%; p=0.004). A combined PCA demonstrated clustering of patients with classical and non-classical CAH by serum 17-hydroxyprogesterone (17-OHP) and dehydroepiandrosterone-sulphate (DHEAS) concentrations. Conclusion: As an example of the possibilities of PCA, endocrine profiles were successfully able to distinguish between patients with CAH according to treatment efficacy and to elucidate biochemical differences between classical and non-classical CAH.
Original language | English |
---|---|
Article number | 652888 |
Journal | Frontiers in Endocrinology |
Volume | 12 |
ISSN | 1664-2392 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
Funding Information:
ML was funded by the Absalon Foundation.
Publisher Copyright:
© Copyright © 2021 Ljubicic, Madsen, Juul, Almstrup and Johannsen.
- CAH, congenital adrenal hyperplasia, endocrine profiling, principal component analysis, treatment efficacy
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 284201801